1 / 6

How do you manage this patient?

How do you manage this patient?. Medical management. should include treatment of possible complications: Respiratory tract infections Arrhythmias, atrial fibrillation, supraventricular tachycardia Pulmonary hypertension, coronary artery disease, heart failure Infective endocarditis.

matt
Download Presentation

How do you manage this patient?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. How do you manage this patient?

  2. Medical management • should include treatment of possible complications: • Respiratory tract infections • Arrhythmias, atrial fibrillation, supraventricular tachycardia • Pulmonary hypertension, coronary artery disease, heart failure • Infective endocarditis Harrison’s Principles of Internal Medicine 17th ed.

  3. Surgical management • Operative repair – definitive management • with a patch of pericardium OR • prosthetic material OR • percutaneous transcatheter device closure should be advised for all patients with uncomplicated secundum atrial septal defects with significant left-to-right shunting Harrison’s Principles of Internal Medicine 17th ed.

  4. Indications The mere presence of an ASD may warrant intervention especially if there is a significant shunt (> 2:1) • symptomatic • pulmonary hypertension is present [pulmonary artery pressure (PAP) > 2/3 systemic arterial blood pressure (SABP) or • pulmonary arteriolar resistance > 2/3 systemic arteriolar resistance • net left-to-right shunt (Qp:Qs) of at least 1.5:1 • RA or RV enlargement – radiographic, cardiac catheterization • or there is evidence of pulmonary artery reactivity when challenged with a pulmonary vasodilator (e.g. oxygen, nitric oxide and/or prostaglandins) • or lung biopsy evidence shows that pulmonary arterial changes are potentially reversible Schwartz ‘s Principles of Surgery, 9th ed. http://www.achd-library.com/index.html

  5. Device closure may now be offered as an alternative to surgical closure to patients with secundum ASD of up to 36-38 mm in diameter Surgical closure may also be offered, and may be especially attractive should the patient prefer the surgical approach, or especially if atrial arrhythmia surgery (atrial maze procedure for atrial fibrillation and radiofrequency or cryoablation for atrial flutter) may be offered concurrently http://www.achd-library.com/index.html

  6. The following ASD patients require periodic follow up by an ACHD cardiologist • Those repaired as adults • Elevated pulmonary artery pressures at the time of repair • Atrial arrhythmias pre- or post-operatively • Ventricular dysfunction pre-operatively • Co-existing heart disease (e.g. coronary artery disease, valvular heart disease, hypertension) • Those with device closure need follow-up in specialized centers with serial ECGs and echocardiograms to determine the late outcomes of these new techniques • Endocarditis prophylaxis and aspirin are recommended for 6 months following device closure http://www.achd-library.com/index.html

More Related